FDA Approves First Generic Versions of Farxiga (Dapagliflozin) In a significant move for patient access and healthcare affordability, the U.S. Food and Drug Administration (FDA) approved the first generic versions …
Tag:
Fierce Pharma Homepage
-
-
FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
-
China Approves First Commercially Available Brain-Computer Interface China has taken a significant step forward in neurotechnology, granting commercial approval for the country’s first brain-computer interface (BCI) device. Developed by Shanghai-based …
-
AstraZeneca, Joshua Jackson, and Gritty Team Up to Promote Cancer Screenings AstraZeneca has launched the third year of its “Get Body Checked Against Cancer” campaign, enlisting actor Joshua Jackson and …
-
Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle Table of Contents Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle FDA Launches Investigation …